Literature DB >> 24706108

Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins.

S Capossela1, P Schläfli, A Bertolo, T Janner, B M Stadler, T Pötzel, M Baur, J V Stoyanov.   

Abstract

Degeneration of intervertebral discs (IVDs) is associated with back pain and elevated levels of inflammatory cells. It has been hypothesised that discogenic pain is a direct result of vascular and neural ingrowth along annulus fissures, which may expose the avascular nucleus pulposus (NP) to the systemic circulation and induce an autoimmune reaction. In this study, we confirmed our previous observation of antibodies in human degenerated and post-traumatic IVDs cultured in vitro. We hypothesised that the presence of antibodies was due to an autoimmune reaction against specific proteins of the disc. Furthermore we identified antigens which possibly trigger an autoimmune response in degenerative disc diseases. We demonstrated that degenerated and post-traumatic IVDs contain IgG antibodies against typical extracellular proteins of the disc, particularly proteins of the NP. We identified IgGs against collagen type II and aggrecan, confirming an autoimmune reaction against the normally immune privileged NP. We also found specific IgGs against collagens types I and V, but not against collagen type III. In conclusion, this study confirmed the association between disc degeneration and autoimmunity, and may open the avenue for future studies on developing prognostic, diagnostic and therapy-monitoring markers for degenerative disc diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24706108     DOI: 10.22203/ecm.v027a18

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  13 in total

Review 1.  Treatment of Discogenic Low Back Pain: Current Treatment Strategies and Future Options-a Literature Review.

Authors:  Lei Zhao; Laxmaiah Manchikanti; Alan David Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2019-11-09

2.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

3.  Interleukin-1β and cathepsin D modulate formation of the terminal complement complex in cultured human disc tissue.

Authors:  Graciosa Q Teixeira; Zhiyao Yong; Amelie Kuhn; Jana Riegger; Raquel M Goncalves; Michael Ruf; Uwe M Mauer; Markus Huber-Lang; Anita Ignatius; Rolf E Brenner; Cornelia Neidlinger-Wilke
Journal:  Eur Spine J       Date:  2021-06-24       Impact factor: 3.134

4.  Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.

Authors:  Peyman Sahbaie; Wen-Wu Li; Tian-Zhi Guo; Xiao-You Shi; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2021-10-23       Impact factor: 5.820

5.  Optimisation of high-quality total ribonucleic acid isolation from cartilaginous tissues for real-time polymerase chain reaction analysis.

Authors:  M Peeters; C L Huang; L A Vonk; Z F Lu; R A Bank; M N Helder; B Zandieh Doulabi
Journal:  Bone Joint Res       Date:  2016-11       Impact factor: 5.853

Review 6.  Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration.

Authors:  Weihang Li; Shilei Zhang; Dong Wang; Huan Zhang; Quan Shi; Yuyuan Zhang; Mo Wang; Ziyi Ding; Songjie Xu; Bo Gao; Ming Yan
Journal:  Front Cell Dev Biol       Date:  2022-02-10

Review 7.  The involvement of immune system in intervertebral disc herniation and degeneration.

Authors:  Fubiao Ye; Feng-Juan Lyu; Hua Wang; Zhaomin Zheng
Journal:  JOR Spine       Date:  2022-03-15

Review 8.  Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review.

Authors:  Takashi Ohnishi; Norimasa Iwasaki; Hideki Sudo
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

9.  Novel cytogenic and neurovascular niches due to blood-brain barrier compromise in the chronic pain brain.

Authors:  Maral Tajerian; J David Clark
Journal:  Mol Pain       Date:  2015-10-09       Impact factor: 3.395

Review 10.  The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment.

Authors:  Zhen Sun; Bing Liu; Zhuo-Jing Luo
Journal:  Int J Med Sci       Date:  2020-02-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.